Industries > Pharma > Advanced Wound Care: World Market Prospects 2013-2023

Advanced Wound Care: World Market Prospects 2013-2023

PUBLISHED: 28 November 2012
PAGES: 171

WOOCS 2.2.1

The demand for advanced wound care products is expected to rise over the next 10 years, driven by an increase in chronic wounds. This can be attributed to an aging population and an increase in lifestyle related disorders such as diabetes and obesity. Visiongain predicts the total advanced wound care market to be worth $16.3bn in 2023.

The move from traditional wound care treatment to advanced wound care started in the mid 80’s, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.

Visiongain’s report Advanced Wound Care: World Market Prospects 2013-2023 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size and the growth of leading sub segments from 2013-2023. This report also discusses the leading companies operating in this space and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market. There are 115 tables and figures included. Visiongain has determined that the value of the global advanced wound care market will reach $16.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Advanced Wound Care: World Market Prospects 2013-2023

• 148 pages of comprehensive analysis
• 2 Exclusive Visiongain interviews with experts from-
– Derma Sciences
– Shire Regenerative Medicine
• 115 tables, charts, and graphs
• Global advanced wound care market forecast between 2012-2023
• 3 advanced wound care submarket forecasts from 2012-2023
– Moist Wound Care
– Wound Care Devices
– Wound Care Biologics
• SWOT analysis for each submarket
• Several leading companies identified and 6 profiled –
– Kinetic Concepts Inc (KCI)
– Smith & Nephew (S&N)
– Molnlycke Health Care
– ConvaTec
– Systagenix Wound Management
– Coloplast

You can order this report today

Gain an understanding of the overall advanced wound care market and the leading companies operating in this market by ordering Advanced Wound Care: World Market Prospects 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Advanced Wound Care: World Market Prospects 2013-2023

Download sample pages

Complete the form below to download your free sample pages for Advanced Wound Care: World Market Prospects 2013-2023

Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021


Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021